OKYO Pharma (LSE:OKYO) Accumulated other comprehensive income (loss) : £-9.44 Mil (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is OKYO Pharma Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. OKYO Pharma's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2023 was £-9.44 Mil.

OKYO Pharma's quarterly Accumulated other comprehensive income (loss) increased from Mar. 2022 (£-8.36 Mil) to Sep. 2022 (£-0.05 Mil) but then declined from Sep. 2022 (£-0.05 Mil) to Mar. 2023 (£-9.44 Mil).

OKYO Pharma's annual Accumulated other comprehensive income (loss) declined from Mar. 2021 (£-7.34 Mil) to Mar. 2022 (£-8.36 Mil) and declined from Mar. 2022 (£-8.36 Mil) to Mar. 2023 (£-9.44 Mil).

OKYO Pharma Accumulated other comprehensive income (loss) Historical Data

The historical data trend for OKYO Pharma's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OKYO Pharma Accumulated other comprehensive income (loss) Chart

OKYO Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-7.34

-8.36

-9.44

OKYO Pharma Semi-Annual Data
	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-7.34	-0.01	-8.36	-0.05	-9.44

OKYO Pharma Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

OKYO Pharma Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of OKYO Pharma's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

OKYO Pharma (LSE:OKYO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OKYO Pharma Ltd (LSE:OKYO) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

OKYO:USA OK10:Germany

Address

14/15 Conduit St, Floor 4, London, GBR, W1S 2XJ

Website

https://www.okyopharma.com

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.